Health Legislation

The Proclamation establishes an Ethiopian Identity System applicable to any person residing in Ethiopia.  

This regulation is issued to implement the Food and Medicine Administration Proclamation No.1112/2019. It provides the organization, powers and duties of the Ethiopian Food and Drug Authority.

This regulation is issued to implement Proclamation No. 1273/2022 Community-Based Health Insurance Proclamation. It establishes the framework for managing health insurance pools and reserve funds (Sections 3-6), outlines membership and contribution procedures (Sections 7-9), and details provider payment mechanisms (Section 10). It also addresses fund management, financial deficit coverage (Sections 11-13), and miscellaneous provisions such as co-payment and data management (Sections 14-20).

The National Health Insurance Scheme Medicines List of 2023 provides a revised version of the Medicines List.

This regulation establishes the rules applicable to the exercise of pharmaceutical activity, in the public and private sectors, by natural or legal persons.

This Proclamation provides the legal framework for the Community Based Health Insurance System.

The purpose of this Law is to establish mechanisms for the protection and promotion of health, the prevention and control of diseases, as well as threats and risks to public health.

The Proclamation 1263/2021 was enacted to provide for the definition of the powers and duties of the executive organs of the federal democratic republic of Ethiopia. It includes provisions regarding the mandate of the Ministry of Health (cf. section 35).

The Insurance Act of 2021 establishes the National Insurance Commission, and provides for the regulation and supervision of the insurance market and related matters.

The Resolution approves the Health Policy and the Strategy for its Implementation.

This document provides the national list of essential medicines and other health products in Ethiopia. 

This Law establishes the Disaster Risk Management and Reduction Legal Regime, which comprises risk reduction, disaster management, sustainable recovery for building human, infrastructural and ecosystem resilience, as well as adaptation to climate change.

The Decree approves the Organic Statute of the Autoridade Nacional Reguladora de Medicamento (The National Medicines Regulatory Authority). The purpose of this Decree is to define the rules governing the organization, management and operation, as well as the powers of its bodies.

This Proclamation is to provide for Food and Medicine Administration. It provides rules to regulate several areas including food, medicine, medical devices, cosmetics, and tobacco products.

The Right to Information Act of 2019 provides for the implementation of the constitutional right to information held by a public institution, subject to the exemptions that are necessary and consistent with the protection of the public interest in a democratic society, to foster a culture of transparency and accountability in public affairs and to provide for related matters.

The diploma approves the rules of Procedure of the Ministry of Health.

The law modifies the articles 8, 135,137,139,159,160,166,195,204,226,244,250,275,292 and the title XII of the Constitution of the Republic of Mozambique. 

The National Identity Register (Amendment) Act of 2017 amends the National Identity Register Act, 2008 (Act 750), to make further provision for the mode of application for identity cards, provide for the conditions and requirements for registration, prescribe information to be supplied by persons to whom national identity cards are to be issued and for related matters.

The Local Governance (Amendment) Act of 2017 amends the Local Governance Act, 2016 (Act 936) to provide for the discretion of the President to revoke the appointment of an appointed member of a District Assembly.

The Essential Medicines List of Ghana of 2017 is a comprehensive guide outlining the medicines deemed essential for addressing the primary health care needs of the population. It includes a wide range of medications selected based on their relevance to public health, evidence on efficacy and safety, and comparative cost-effectiveness, aimed at ensuring accessibility and affordability.